Rasio rega marang bathi NeuroOne (NMTC)

The linear price action on the chart demonstrates the -0.90 metric, characterizing NeuroOne Medical Technologies (NMTC). NeuroOne Medical Technologies (NMTC) develops unique neuromapping electrodes, providing the company with significant pricing power and high profitability. Growth is driven by FDA approvals and alliances with major distributors. Furthermore, the business relies on a stable US legal framework, shielded from geopolitical risks and trade conflicts.

NeuroOne Medical Technologies (NMTC) is scaling the delivery of precision neurosurgical electrodes, enabling high-accuracy diagnostics for epilepsy and Parkinson's disease. The ratio of market capitalization to net income reflects the cost per unit of earnings, allowing the company's historical P/E range to identify anomalies in the pricing process and assess the fairness of the current market value of assets during this phase of active business growth.